Gilmore Nathan T, Alsbrooks Kimberly, Hoerauf Klaus
Department of Critical Care, Hoag Health Center Newport Beach, Newport Beach, CA.
Medical Affairs, Becton, Dickinson, and Company, Franklin Lakes, NJ.
Crit Care Explor. 2023 Jan 6;5(1):e0795. doi: 10.1097/CCE.0000000000000795. eCollection 2023 Jan.
Dialysis catheter type may be associated with differences in continuous renal replacement therapy (CRRT) treatment in the critically ill, with potential implications for patient outcomes and healthcare costs.
To evaluate the association between the catheter type and multiple dialysis treatment outcomes among the critically ill.
Retrospective, observational study.
Two U.S.-based ICUs.
Critically ill patients receiving CRRT between April 1, 2018, and July 1, 2020. A total of 1,037 CRRT sessions were analyzed.
Circuit life, alarm interruption frequency (including a subset of vascular access [VA]-related alarms), termination type (elective vs nonelective), and blood flow rates. Pre- ( = 530) and post-catheter change ( = 507) periods were assessed, and the post-change period was further divided into intervals of pre-COVID ( = 167) and COVID contemporaneous ( = 340) to account for the pandemic's impact.
Compared with pre-change sessions, post-change sessions had 31% longer circuit life (95% CI, 1.14-1.49; < 0.001), 3% higher blood flow rate (1.01-1.05; < 0.01), and lower proportion of nonelective terminations (adjusted odds ratio [OR], 0.42 [0.28-0.62]; < 0.001). There were fewer interruptions for all alarms (adjusted count ratio, 0.95 [0.87-1.05]; = 0.31) and VA-related alarms (0.80 [0.66-0.96]; = 0.014). The sessions during COVID period were statistically similar to pre-COVID sessions for all outcomes except a lower proportion of nonelective terminations (adjusted OR, 0.39 [0.22-0.70]; < 0.01).
A change in catheter type was associated with longer CRRT sessions with fewer interruptions and unexpected terminations in a population of critical patients.
透析导管类型可能与危重症患者的连续性肾脏替代治疗(CRRT)存在差异,这对患者预后和医疗成本可能产生影响。
评估导管类型与危重症患者多种透析治疗结局之间的关联。
回顾性观察研究。
美国的两家重症监护病房。
2018年4月1日至2020年7月1日期间接受CRRT的危重症患者。共分析了1037次CRRT治疗。
管路使用寿命、报警中断频率(包括与血管通路[VA]相关的报警子集)、终止类型(择期与非择期)以及血流量。评估了导管更换前(n = 530)和更换后(n = 507)两个阶段,更换后阶段进一步分为COVID前(n = 167)和COVID同期(n = 340)两个时间段,以考虑疫情的影响。
与更换前的治疗相比,更换后的治疗管路使用寿命延长31%(95%置信区间,1.14 - 1.49;P < 0.001),血流量提高3%(1.01 - 1.05;P < 0.01),非择期终止的比例降低(调整后的优势比[OR],0.42 [0.28 - 0.62];P < 0.001)。所有报警的中断次数减少(调整后的计数比,0.95 [0.87 - 1.05];P = 0.31),与VA相关的报警中断次数减少(0.80 [0.66 - 0.96];P = 0.014)。除了非择期终止比例较低(调整后的OR,0.39 [0.22 - 0.70];P < 0.01)外,COVID期间的治疗在所有结局方面与COVID前的治疗在统计学上相似。
在危重症患者群体中,导管类型的改变与更长的CRRT治疗时间、更少的中断和意外终止相关。